Resources from the same session
LBA38 - Bexmarilimab, a novel macrophage re-programmer shows promising anti-tumour activity in phase I/II trial in several last line solid tumour types
Presenter: Petri Bono
Session: Proffered Paper session - Investigational immunotherapy
Resources:
Abstract
Slides
Webcast
957O - Long-term follow-up of patients (pts) with human papillomavirus (HPV)–associated malignancies treated with bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1
Presenter: James Gulley
Session: Proffered Paper session - Investigational immunotherapy
Resources:
Abstract
Slides
Webcast
958O - Coordinated activation of antitumor responses of g9d2 and CD8 T-cells by targeting BTN3A with ICT01 in patients with solid tumors: EVICTION trial
Presenter: Aurélien Marabelle
Session: Proffered Paper session - Investigational immunotherapy
Resources:
Abstract
Slides
Webcast
959O - Gavocabtagene autoleucel (gavo-cel, TC-210) dose escalation in refractory mesothelin-expressing solid tumors
Presenter: David S. Hong
Session: Proffered Paper session - Investigational immunotherapy
Resources:
Abstract
Slides
Webcast
Invited Discussant LBA38, 957O and 958O
Presenter: Sebastian Kobold
Session: Proffered Paper session - Investigational immunotherapy
Resources:
Slides
Webcast
Invited Discussant 959O
Presenter: Alessandra Curioni
Session: Proffered Paper session - Investigational immunotherapy
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Alessandra Curioni
Session: Proffered Paper session - Investigational immunotherapy
Resources:
Slides
Webcast